SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

National Healthcare Corp. – ‘8-K’ for 2/16/24

On:  Friday, 2/16/24, at 5:12pm ET   ·   For:  2/16/24   ·   Accession #:  1437749-24-4621   ·   File #:  1-13489

Previous ‘8-K’:  ‘8-K’ on / for 2/9/24   ·   Latest ‘8-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/16/24  National Healthcare Corp.         8-K:2,9     2/16/24   12:393K                                   RDG Filings/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    220K 
 7: R1          Document And Entity Information                     HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
12: XML         XBRL Instance -- nhc20240215_8k_htm                  XML     14K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- nhc-20240216_def                 XML     37K 
 5: EX-101.LAB  XBRL Labels -- nhc-20240216_lab                      XML     47K 
 6: EX-101.PRE  XBRL Presentations -- nhc-20240216_pre               XML     36K 
 3: EX-101.SCH  XBRL Schema -- nhc-20240216                          XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001437749-24-004621-xbrl      Zip     26K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C: 
 i false  i 0001047335 0001047335 2024-02-16 2024-02-16
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM  i 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): February 16, 2024 ( i February 16, 2024)
 

 
 i NATIONAL HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 

 
 i Delaware
(State or other jurisdiction of
incorporation)
(Commission File Number)
 i 52-2057472
(I.R.S. Employer Identification
No.)
     
 i 100 E. Vine Street
 i Murfreesboro,  i Tennessee
(Address of Principal Executive
Offices)
 
 i 37130
(Zip Code)
 
Registrants telephone number, including area code: ( i 615)  i 890-2020
 
Not Applicable
(Former name or former address, if changed since last report)
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 i  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 i  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
 i Common Stock, $.01 par value
 i NHC
 i NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company  i 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
ITEM 2.02.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
National HealthCare Corporation (“NHC”) issued a press release on February 16, 2024, announcing its December 31, 2023 earnings. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.
 
 
ITEM 9.01.
FINANCIAL STATEMENTS AND EXHIBITS.
 
(d)         Exhibits.
 
Exhibit No.
Description of Exhibit
99.1
   
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:         February 16, 2024
 
 
NATIONAL HEALTHCARE CORPORATION
 
       
       
 
By:
/s/ 
Brian F. Kidd
 
 
Name:
Title:
Brian F. Kidd
Senior VP/Chief Financial Officer
 
 
 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:2/16/2410-K
12/31/2310-K,  5
 List all Filings 
Top
Filing Submission 0001437749-24-004621   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 2:14:19.1am ET